CollPlant Biotechnologies (CLGN) Change in Accrued Expenses (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Change in Accured Expenses of $323,000 for the quarter ended Jun 30, 2026, up 137.5% from $136,000 a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Change in Accrued Expenses (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CollPlant Biotechnologies' Change in Accured Expenses came in at $373,000; for the year ended Dec 31, 2025, it came in at -$46,000.
- By year, Change in Accured Expenses came in at -$353,000 in the year ended Dec 31, 2024, $204,000 in the year ended Dec 31, 2023, $14,000 in the year ended Dec 31, 2022 and -$464,000 in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Change in Accured Expenses since the quarter ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | CollPlant Biotechnologies | 4.98 Mn | -17.38 Mn | -456,000.00 | 323,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 323,000.00 |
| Mar 31, 2026 | -235,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Jun 30, 2025 | 136,000.00 |
| Mar 31, 2025 | -96,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Jun 30, 2024 | -394,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Sep 30, 2023 | -102,000.00 |
| Jun 30, 2023 | -88,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 476,000.00 |
| Sep 30, 2022 | -157,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | -333,000.00 |
| Dec 31, 2021 | 472,000.00 |
| Sep 30, 2021 | -627,000.00 |
API Access
CollPlant Biotechnologies Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();